​
Login / Signup
Ying Liu
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 4
Top Topics
Phase Ii
Young Adults
Bone Marrow
Platelet Rich Plasma
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
JNCI cancer spectrum
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mary L Disis
,
Yushe Dang
,
Andrew L Coveler
,
Jennifer S Childs
,
Doreen M Higgins
,
Ying Liu
,
Jing Zhou
,
Sean Mackay
,
Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Mary L Disis
,
Yushe Dang
,
Andrew L Coveler
,
Jennifer S Childs
,
Doreen M Higgins
,
Ying Liu
,
Jing Zhou
,
Sean Mackay
,
Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Mary L Disis
,
Yushe Dang
,
Andrew L Coveler
,
Jennifer S Childs
,
Doreen M Higgins
,
Ying Liu
,
Jing Zhou
,
Sean Mackay
,
Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Guochong Jia
,
Yingchang Lu
,
Wanqing Wen
,
Jirong Long
,
Ying Liu
,
Ran Tao
,
Bingshan Li
,
Joshua C Denny
,
Xiao-Ou Shu
,
Quan Long
Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers.
JNCI cancer spectrum
4 (3) (2020)